HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR

·1d ago
Share:PostShare

Findings build on the established success of the global SAFFRON and China SACHI trials, extending the clinical value of the all-oral combination into the first-line setting Findings build on the established success of the global SAFFRON and China SACHI trials, extending the clinical value of the all-oral combination into the first-line setting

G

Globe Newswire

Original source

Read full story

plus

Check live status on DownRightNow

Check status →

Related Stories

Health11h ago

NSW's historic MND data drive - Shepparton News

NSW's historic MND data drive Shepparton News New hope in quest to solve mystery of MND hotspots ABC News & Headlines – Australian Broadcasting Corporation Major MND move must go nationwide for research boost The Canberra Times Your risk of Motor Neurone Disease where you live: "Australians would be shocked". SBS Incurable disease spreads, cause unknown News.com.au

GGoogle News

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer